UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$204M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
+$163M |
| 3 |
Visa
V
|
+$141M |
| 4 |
Alibaba
BABA
|
+$137M |
| 5 |
Freeport-McMoran
FCX
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
K
Kellanova
K
|
+$196M |
| 2 |
Infosys
INFY
|
+$163M |
| 3 |
Monster Beverage
MNST
|
+$144M |
| 4 |
Mastercard
MA
|
+$128M |
| 5 |
Procter & Gamble
PG
|
+$119M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.83% |
| 2 | Technology | 14.48% |
| 3 | Financials | 14.28% |
| 4 | Consumer Discretionary | 9% |
| 5 | Industrials | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
United Therapeutics
UTHR
$21.8B
| $6.82M | 0.01% |
53,034
+3,840
| +8% | +$396K |
|
927
Innoviva
INVA
$1.6B
| $6.8M | 0.01% |
397,897
-372,500
| -48% | -$8.56M |
|
928
Petrobras
PBR
$119B
| $6.8M | 0.01% |
479,040
-17,955
| -4% | -$300K |
|
|
DFRG
929
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
| $6.77M | 0.01% |
353,694
-28,691
| -8% | -$653K |
|
930
Ambev
ABEV
$47B
| $6.73M | 0.01% |
+1,027,040
| New | +$7.23M |
|
931
Constellium
CSTM
$4.02B
| $6.71M | 0.01% |
272,500
-25,905
| -9% | -$747K |
|
|
DHC
932
Diversified Healthcare Trust
DHC
$2.19B
| $6.63M | 0.01% |
319,520
-7,265
| -2% | -$165K |
|
933
Rio Tinto
RIO
$164B
| $6.61M | 0.01% |
134,358
-20,912
| -13% | -$1.15M |
|
934
Vodafone
VOD
$36.8B
| $6.61M | 0.01% |
200,923
+3,945
| +2% | +$132K |
|
935
Woodward
WWD
$22.4B
| $6.6M | 0.01% |
138,615
-5,183
| -4% | -$262K |
|
|
HTWR
936
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $6.58M | 0.01% |
84,736
+44,523
| +111% | +$3.69M |
|
|
TMH
937
DELISTED
Team Health Holdings Inc
TMH
| $6.55M | 0.01% |
112,942
+84,044
| +291% | +$4.69M |
|
938
ATI
ATI
$32.1B
| $6.54M | 0.01% |
176,403
+5,509
| +3% | +$232K |
|
939
Omega Healthcare
OHI
$14.7B
| $6.52M | 0.01% |
190,592
-7,700
| -4% | -$283K |
|
|
TE
940
DELISTED
TECO ENERGY INC
TE
| $6.46M | 0.01% |
371,502
+18,993
| +5% | +$336K |
|
|
STR
941
DELISTED
QUESTAR CORP
STR
| $6.39M | 0.01% |
286,664
-336,011
| -54% | -$7.74M |
|
|
NSR
942
DELISTED
Neustar Inc
NSR
| $6.34M | 0.01% |
255,398
| – | – |
|
943
LSB Industries
LXU
$698M
| $6.33M | 0.01% |
230,307
-21,584
| -9% | -$642K |
|
944
IDEX
IEX
$17.5B
| $6.33M | 0.01% |
87,401
+673
| +0.8% | +$51.9K |
|
|
JMEI
945
DELISTED
Jumei International Holding Limited American depositary shares, each representing ten Class A ordina
JMEI
| $6.32M | 0.01% |
+26,910
| New | +$7.85M |
|
946
Community Health Systems
CYH
$417M
| $6.28M | 0.01% |
138,645
+2,057
| +2% | +$85.5K |
|
947
Huntington Ingalls Industries
HII
$12.6B
| $6.25M | 0.01% |
60,007
+1,000
| +2% | +$98.5K |
|
|
ALE
948
DELISTED
Allete
ALE
| $6.25M | 0.01% |
140,799
-46,300
| -25% | -$2.22M |
|
949
SS&C Technologies
SSNC
$18.5B
| $6.18M | 0.01% |
281,832
+1,510
| +0.5% | +$33.4K |
|
950
iShares Russell 2000 Growth ETF
IWO
$14.9B
| $6.12M | 0.01% |
47,200
+18,500
| +64% | +$2.48M |
|
Similar funds
UBS AM's Q3 2014 Portfolio in Review
As of Q3 2014, UBS AM held 2,623 positions worth $101B, up 1.8% from $99B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS AM's Q3 2014 filing shows 68 new, 1,056 increased, 515 reduced and 65 closed positions. Its largest new stake was Alibaba: 1,521,250 shares worth $135M. The largest sale was Kellanova, an estimated $196M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q3 2014 buy was Alibaba: 1,521,250 shares worth $135M.
- UBS AM added most to Apple in Q3 2014, an estimated $204M increase.
- UBS AM's biggest Q3 2014 reduction was Kellanova, cutting an estimated $196M.
- UBS AM fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $80.9M.
- UBS AM's ten largest holdings make up 15% of its $101B portfolio in Q3 2014.
- UBS AM opened 68 new positions and closed 65 in Q3 2014.
- UBS AM's portfolio value rose 1.8% quarter-over-quarter to $101B.
Based on UBS AM's 13F filing for Q3 2014, filed 28 Oct 2014.